KalVista Pharmaceuticals, Inc. (KALV) Net Cash Provided by (Used in) Financing Activities USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • KalVista Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending July 31, 2023 was $204 K, a 21.4% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $58.1 M, a 3576% increase from 2021.
  • KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $1.58 M, a 99.3% decline from 2020.
  • KalVista Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $212 M, a 1731% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $204 K +$36 K +21.4% May 1, 2023 Jul 31, 2023 10-Q 2023-09-07
Q2 2022 $168 K -$440 K -72.4% May 1, 2022 Jul 31, 2022 10-Q 2023-09-07
Q2 2021 $608 K +$562 K +1222% May 1, 2021 Jul 31, 2021 10-Q 2022-09-08
Q2 2020 $46 K -$11.4 M -99.6% May 1, 2020 Jul 31, 2020 10-Q 2021-09-09
Q2 2019 $11.4 M +$6.45 M +130% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q2 2018 $4.95 M May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.